IIM
DNA icon

INTECH Investment Management’s Ginkgo Bioworks DNA Stock Holding History

INTECH Investment Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105K Sell
10,605
-1,701
-14% -$14.2K ﹤0.01% 1938
2026
Q1 		$75.4K Sell
12,306
-2,181
-15% -$18.1K ﹤0.01% 1947
2025
Q4 		$120K Sell
14,487
-1,322
-8% -$14.2K ﹤0.01% 2118
2025
Q3 		$230K Sell
15,809
-4,000
-20% -$47.9K ﹤0.01% 1986
2025
Q2 		$223K Buy
+19,809
New +$153K ﹤0.01% 2033

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

INTECH Investment Management's DNA Position: Q2 2026 in Review

INTECH Investment Management reduced its Ginkgo Bioworks (DNA) stake by 14% in Q2 2026, selling an estimated $14.2K and leaving 10,605 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #1938.

INTECH Investment Management first reported a position in DNA in Q2 2025 and has held it in 5 quarters since. The position peaked at $230K in Q3 2025. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • INTECH Investment Management held 10,605 shares of Ginkgo Bioworks worth $105K as of Q2 2026.
  • INTECH Investment Management sold 1,701 Ginkgo Bioworks shares in Q2 2026, an estimated $14.2K.
  • Ginkgo Bioworks made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1938 holding.
  • INTECH Investment Management first reported a position in Ginkgo Bioworks in Q2 2025 and has held it in 5 quarters since.
  • INTECH Investment Management's Ginkgo Bioworks position peaked at $230K in Q3 2025.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.